[PubMed] [Google Scholar] 16.Lowry O
Our formulation includes glycine to protect muscle mass and B12 to reduce nausea during dose increases
For type 2 diabetes , NICE guideline NG28 recommends GLP-1 receptor agonists in specific circumstances, including: As part of triple therapy (with metformin and either a sulfonylurea or pioglitazone) when dual therapy with metformin and another oral drug has not achieved adequate glycaemic control As part of triple therapy with metformin and a sodium-glucose cotransporter 2 (SGLT2) inhibitor if certain criteria are met In combination with insulin, with or without other antidiabetic drugs Treatment should be continued only if there is a beneficial metabolic response (reduction of at least 11 mmol/mol in HbA1c and weight loss of at least 3% at 6 months)
Supporting muscle and nerve function: Beyond tendons and ligaments, research suggests that BPC-157 may stabilize the junctions between nerves and muscles, preserve acetylcholine receptors (the chemical messengers at nerve-muscle connections), and enhance muscle regeneration while reducing scar tissue formation
In laboratory models, Dihexa binds to HGF with high affinity, essentially supercharging the factors ability to activate the c-Met receptor
